

Lead Product(s) : Nilvadipine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study shows Nilvadipine slows early-stage Alzheimer’s disease
Details : The data from the trial showed that early-stage Alzheimer’s patients who were taking Nilvadipine showed less cognitive decline over an 18-month period than patients treated with placebo.
Product Name : Nilvadil
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 06, 2020
Lead Product(s) : Nilvadipine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Nilvadipine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : University of Dublin, Trinity College | Molecular Medicine Ireland LBG | Alzheimer Europe | Archer Pharmaceuticals, Inc. | E-Search Limited | University College Dublin | King's College London | Istituto Mario Negri | University Hospital, Lille | Universit
Deal Size : Inapplicable
Deal Type : Inapplicable
A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
Details : Nilvadipine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 20, 2013
Lead Product(s) : Nilvadipine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : University of Dublin, Trinity College | Molecular Medicine Ireland LBG | Alzheimer Europe | Archer Pharmaceuticals, Inc. | E-Search Limited | University College Dublin | King's College London | Istituto Mario Negri | University Hospital, Lille | Universit
Deal Size : Inapplicable
Deal Type : Inapplicable


 
															 Reset All
Reset All